Difference between revisions of "Paul Hastings"
From QueerBio.com
| (2 intermediate revisions by the same user not shown) | |||
| Line 14: | Line 14: | ||
==Description== | ==Description== | ||
| − | Chief Executive Officer of Nkarta Therapeutics, a company developing natural killer cells to fight cancer, since 2018. Chairman of BIO, the industry's trade association. Former CEO of OncoMed Pharmaceuticals. | + | Chief Executive Officer of Nkarta Therapeutics, a company developing natural killer cells to fight cancer, since 2018. Chairman of BIO, the industry's trade association. Member of the Board of Pacira BioSciences, Inc. and Engene Holdings. Former CEO of OncoMed Pharmaceuticals. |
==See Also== | ==See Also== | ||
| Line 20: | Line 20: | ||
* [[LGBTQ Cancer Research and Support]] | * [[LGBTQ Cancer Research and Support]] | ||
* [[LGBTQ Chief Executive Officers of Business Enterprises]] | * [[LGBTQ Chief Executive Officers of Business Enterprises]] | ||
| + | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] | ||
==Further Reading/Research== | ==Further Reading/Research== | ||
Latest revision as of 18:35, 25 May 2024
Country
United States
Birth - Death
Occupation
Business
Description
Chief Executive Officer of Nkarta Therapeutics, a company developing natural killer cells to fight cancer, since 2018. Chairman of BIO, the industry's trade association. Member of the Board of Pacira BioSciences, Inc. and Engene Holdings. Former CEO of OncoMed Pharmaceuticals.
See Also
- LGBTQ Cancer Research and Support
- LGBTQ Chief Executive Officers of Business Enterprises
- LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies
